Therapeutic proteins are widely used in modern pharmaceutics, but their clinical efficacy is often limited by rapid clearance, poor stability, and high immunogenicity. Polyethylene glycol (PEG) has been extensively employed to improve protein stability, prolong circulation half-life, and provide immune shielding. However, growing evidence has highlighted important limitations of PEG, including the prevalence of pre-existing anti-PEG antibodies and the induction of anti-PEG antibody responses following exposure to PEGylated drugs. Anti-PEG antibodies can lead to accelerated blood clearance of PEG-conjugated therapeutics and, in severe cases, life-threatening hypersensitivity reactions. In this thesis, we synthesized and characterized a novel zwitterionic PEG-based polymer and demonstrated its ability to improve the pharmacokinetics of protein therapeutics. We further evaluated the immunogenicity of polymer-modified proteins and elucidated mechanistic factors underlying the enhanced in vivo performance.
Metrics
1 Record Views
Details
Title
Synthesis and application of zwitterionic PEG
Creators
Yucheng Zhu
Contributors
Hao Cheng (Advisor)
Andrew J. D. Magenau (Advisor)
Awarding Institution
Drexel University
Degree Awarded
Doctor of Philosophy (Ph.D.)
Publisher
Drexel University
Number of pages
116 pages
Resource Type
Dissertation
Language
English
Academic Unit
Materials (Science and) Engineering (Metallurgical Engineering) (1970-2026); College of Engineering (1970-2026); Drexel University